D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Visa
V
|
+$319M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$288M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$226M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
Salesforce
CRM
|
+$204M |
Top Sells
| 1 |
PayPal
PYPL
|
+$504M |
| 2 |
Exxon Mobil
XOM
|
+$356M |
| 3 |
Bank of America
BAC
|
+$244M |
| 4 |
Netflix
NFLX
|
+$182M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.76% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Omega Healthcare
OHI
$12.5B
| $802K | ﹤0.01% |
27,212
-152,493
| -85% | -$4.49M |
|
2502
Veru
VERU
$50.5M
| $802K | ﹤0.01% |
6,959
+1,013
| +17% | +$117K |
|
|
LTRPA
2503
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $800K | ﹤0.01% |
733,966
-15,771
| -2% | -$17.2K |
|
2504
BARK
BARK
$150M
| $797K | ﹤0.01% |
437,952
+34,868
| +9% | +$63.5K |
|
2505
GeneDx Holdings
WGS
$3.56B
| $795K | ﹤0.01% |
27,443
-65,177
| -70% | -$1.89M |
|
|
PRTK
2506
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $795K | ﹤0.01% |
309,564
+191,355
| +162% | +$491K |
|
2507
Repare Therapeutics
RPTX
$75.6M
| $793K | ﹤0.01% |
65,384
-8,857
| -12% | -$107K |
|
2508
TopBuild
BLD
$11.7B
| $791K | ﹤0.01% |
4,803
-1,313
| -21% | -$216K |
|
2509
ONE Gas
OGS
$4.55B
| $787K | ﹤0.01% |
11,175
-36,234
| -76% | -$2.55M |
|
2510
Lyell Immunopharma
LYEL
$246M
| $786K | ﹤0.01% |
5,362
-8,080
| -60% | -$1.18M |
|
|
CBAY
2511
DELISTED
Cymabay Therapeutics
CBAY
| $786K | ﹤0.01% |
224,613
-40,728
| -15% | -$143K |
|
2512
Karyopharm Therapeutics
KPTI
$55.9M
| $785K | ﹤0.01% |
9,587
+5,687
| +146% | +$466K |
|
2513
Sapiens International
SPNS
$2.4B
| $785K | ﹤0.01% |
40,919
-43,334
| -51% | -$831K |
|
2514
Cable One
CABO
$968M
| $784K | ﹤0.01% |
919
| – | – |
|
2515
Nurix Therapeutics
NRIX
$691M
| $782K | ﹤0.01% |
+60,014
| New | +$782K |
|
2516
Energy Recovery
ERII
$764M
| $780K | ﹤0.01% |
35,900
+20,100
| +127% | +$437K |
|
2517
Northeast Bank
NBN
$941M
| $780K | ﹤0.01% |
21,272
-4,581
| -18% | -$168K |
|
2518
Sea Limited
SE
$116B
| $779K | ﹤0.01% |
13,900
-55,633
| -80% | -$3.12M |
|
2519
Revvity
RVTY
$9.62B
| $776K | ﹤0.01% |
6,450
+4,713
| +271% | +$567K |
|
2520
Digimarc
DMRC
$204M
| $774K | ﹤0.01% |
57,126
-3,097
| -5% | -$42K |
|
2521
Timken Company
TKR
$5.4B
| $774K | ﹤0.01% |
13,116
-11,656
| -47% | -$688K |
|
2522
Children's Place
PLCE
$155M
| $773K | ﹤0.01% |
25,024
-55,349
| -69% | -$1.71M |
|
2523
Ooma
OOMA
$345M
| $770K | ﹤0.01% |
62,600
-10,938
| -15% | -$135K |
|
|
EIGR
2524
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $770K | ﹤0.01% |
3,407
-5,153
| -60% | -$1.16M |
|
2525
Biomea Fusion
BMEA
$115M
| $764K | ﹤0.01% |
78,082
+57,167
| +273% | +$559K |
|